Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

In an interview with Fortune, Isomorphic Labs president Colin Murdoch shared that four years after its founding, the company ...

A Google parent-owned startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end, marking a significant milestone in pharmaceutical development as ...

The company was spun out of Google DeepMind in 2021, and is built on the breakthrough AlphaFold system, an AI model that ...

Google said it continues to fine-tune MedLM, its large language model for healthcare providers that is trained on medical journals, clinical trials and textbooks.

Google is betting that its generative A.I. can bring new efficiencies to the health care industry. The first health care provider to launch a pilot program for the A.I.-powered note-taking app is ...

Amidst a worker shortage, the healthcare industry has been exploring generative AI and its potential to eliminate mundane, burdensome tasks. On Wednesday, two established organizations — Google ...

Study results . After deduplication, the electronic search for the scoping review produced 10,484 unique records spanning from January 1, 2018, to November 14, 2023.

Pipeline & Deal Updates. Precision Medicine: Healthcare technology company Zephyr AI, which is developing machine learning algorithms based on real-world patient data, announced it has raised a ...

Bill Gates has warned that AI will replace many jobs, but says coding will stay a fully human profession, even hundreds of ...